INS and diabetes mellitus: Participants had an average of 2.4 (1.2) diabetes complications and 2.5 (1.7) co‐morbidities; and 9.2 (9.0) different prescriptions and 1.5 (1.0) different GLTs in the 6 months before study entry; also, 3803 participants (20.0%) had insulin prescriptions during that time.